2017
DOI: 10.1177/1534735417721015
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers

Abstract: Background. Insulin resistance is associated with higher breast cancer (BC) penetrance in BRCA mutation carriers. Metabolic syndrome (MetS), an insulin resistance syndrome, can be reversed by adhering to the Mediterranean diet (MedDiet). In a dietary intervention trial on BRCA mutation carriers, we evaluated adherence to the MedDiet, and the association with the MetS, by analyzing data from the Mediterranean Diet Adherence Screener (MEDAS). Methods. BRCA mutation carriers, with or without BC, aged 18 to 70 yea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
25
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 30 publications
(29 citation statements)
references
References 31 publications
3
25
0
1
Order By: Relevance
“…Might primary prevention options such as lifestyle changes be useful for BRCA mutation carriers? The present results and our previous findings [ 39 ] suggest that women with BRCA mutations may gain from dietary recommendations, with significant improvements in their IRm and metabolic and anthropometric parameters.…”
Section: Discussionsupporting
confidence: 83%
See 3 more Smart Citations
“…Might primary prevention options such as lifestyle changes be useful for BRCA mutation carriers? The present results and our previous findings [ 39 ] suggest that women with BRCA mutations may gain from dietary recommendations, with significant improvements in their IRm and metabolic and anthropometric parameters.…”
Section: Discussionsupporting
confidence: 83%
“…As regards the metabolic and anthropometric parameters, at baseline the two groups were fairly homogeneous. Intervention women were slightly higher ( p = 0.09) and thinner ( p = 0.20), but showed higher levels of triglycerides ( p = 0.09) and insulin ( p = 0.11), and lower levels of High Density Lipoprotein (HDL) cholesterol ( p = 0.19) [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…However, we found no statistically significant differences in the blood pressure and serum glucose among the high and low severity ovarian cancer. Presently, accumulating epidemiological literature has demonstrated that metabolic syndrome (MetS) is closely related to the occurrence and development of several cancers [ 19 ] . The limitations imposed by sample size can be used to explain the phenomenon.…”
Section: Discussionmentioning
confidence: 99%